Compile Data Set for Download or QSAR
Report error Found 263 Enz. Inhib. hit(s) with all data for entry = 10931
TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579449(US11479560, Title ARN-1-770 | US11479560, Title AR...)
Affinity DataEC50: >500nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579287(US11479560, Title KM-4-173-3)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579290(US11479560, Title KM-4-182-2)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579296(US11479560, Title KM-4-207-1)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579271(US11479560, Title ww6-56 | US11479560, Title ww6-6...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579271(US11479560, Title ww6-56 | US11479560, Title ww6-6...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579269(US11479560, Title ww6-39)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579270(US11479560, Title ww6-40)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579276(US11479560, Title DM-27)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579277(US11479560, Title DM-29)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579320(US11479560, Title ww6-268-first)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579322(US11479560, Title ww6-272 | US11479560, Title ww6-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579327(US11479560, Title ww6-308 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579326(US11479560, Title ww6-306 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579298(US11479560, Title KM-4-209-1)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579308(US11479560, Title KM-4-289)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579312(US11479560, Title ww6-130)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579309(US11479560, Title ww6-90)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579351(US11479560, Title WZ-II-104)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579349(US11479560, Title WZ-II-93)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579354(US11479560, Title WZ-II-149 | US11479560, Title WZ...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579359(US11479560, Title WZ-II-184-2)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579360(US11479560, Title WZ-II-186 | US11479560, Title WZ...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579358(US11479560, Title WZ-II-184-1)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579337(US11479560, Title WZ-I-190-2)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579343(US11479560, Title WZ-I-300)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579344(US11479560, Title WZ-I-310)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579341(US11479560, Title WZ-I-283)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579342(US11479560, Title WZ-I-298)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579379(US11479560, Title ARN-1-85 | US11479560, Title ARN...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579379(US11479560, Title ARN-1-85 | US11479560, Title ARN...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579376(US11479560, Title WZ-III-10 | US11479560, Title WZ...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579378(US11479560, Title ARN-1-28)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579383(US11479560, Title ARN-1-223)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579381(US11479560, Title ARN-1-163)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579382(US11479560, Title ARN-1-212)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579387(US11479560, Title ARN-1-255)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579385(US11479560, Title ARN-1-238)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579386(US11479560, Title ARN-1-243)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579391(US11479560, Title ARN-1-269)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579392(US11479560, Title ARN-1-284)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579390(US11479560, Title ARN-1-267)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579360(US11479560, Title WZ-II-186 | US11479560, Title WZ...)
Affinity DataEC50: <1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579367(US11479560, Title WZ-II-208-2 | US11479560, Title ...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Displayed 1 to 50 (of 263 total ) | Next | Last >>
Jump to: